NCT07313384 Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy
| NCT ID | NCT07313384 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of South Carolina |
| Condition | Obesity Type 2 Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-02-11 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-02-11 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The DINE-GLP1 study aims to understand how people on GLP-1 therapy change their eating habits and what kind of dietary support they need. As more people use GLP-1 medications, there's not much guidance on what they should eat, mostly just focusing on managing symptoms and cutting calories. Since these medications reduce food intake, it's important to ensure the diet is nutritious even with fewer calories to help with long-term weight control and health. Most research has looked at how the body responds to the medication and whether patients take it as prescribed, but not much is known about what patients actually experience, what they think they need, or how they could use additional support. Understanding patients' views can help create better lasting solutions. Note that this study does not provide free GLP-1 medication.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 and older * Recently has been prescribed GLP-1 therapy for the treatment of obesity or T2DM but have not yet initiated the medication * Has regular access to a smartphone and internet to complete short surveys and food recalls online * Willing to sign informed consent. Exclusion Criteria: * Already began the GLP-1 medication * Have medical concerns making participation unsafe
Frequently Asked Questions
Who can join the NCT07313384 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Obesity Type 2 Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07313384 currently recruiting?
Yes, NCT07313384 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of South Carolina to inquire about joining.
Where is the NCT07313384 trial being conducted?
This trial is being conducted at Columbia, United States, Greenville, United States.
Who is sponsoring the NCT07313384 clinical trial?
NCT07313384 is sponsored by University of South Carolina. The trial plans to enroll 50 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.